Arrowhead Pharmaceuticals, Inc. (ARWR)

72.80 -5.14 (-6.60%) USD  |  NASDAQ  |  May 08, 16:00
73.93 +1.12 (+1.55%) After-Hours: 18:37
More

Arrowhead Pharmaceuticals EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
Biogen, Inc. Upgrade
Merck & Co., Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade